img

Global Rare Disease Clinical Trial Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Rare Disease Clinical Trial Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Rare Disease Clinical Trial Market
Global Rare Disease Clinical Trial market is expected to reach to US$ 47 million in 2023, with a positive growth of %, compared with US$ 45 million in 2022. Backed with the increasing demand from downstream industries, Rare Disease Clinical Trial industry is evaluated to reach US$ 57 million in 2033. The CAGR will be 3.3% during 2023 to 2033.
The market trend for rare disease clinical trials is experiencing significant growth and development. This can be attributed to several factorsIncreasing focus on rare diseasesRare diseases, also known as orphan diseases, are characterized by a low prevalence in the population. However, collectively, they affect a significant number of individuals worldwide. There is a growing recognition of the need to address the unmet medical needs of patients with rare diseases. As a result, there has been an increased focus on rare diseases in both research and clinical trial development.Regulatory incentivesRegulatory authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have implemented various incentives to encourage the development of treatments for rare diseases. These incentives include orphan drug designation, which provides financial incentives, market exclusivity, and streamlined regulatory processes. These incentives have attracted pharmaceutical companies and researchers to invest in rare disease clinical trials.
Report Covers
This report presents an overview of global Rare Disease Clinical Trial market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Rare Disease Clinical Trial market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Takeda Pharmaceutical Company
F. Hoffmann-La Roche
Pfizer
AstraZeneca
Novartis AG
LabCorp
IQVIA
Charles River Laboratories
Icon PLC
Parexel International Corporation
Segment by Type
Stage I
Phase II

Segment by Application


Autoimmunity and Inflammation
Blood System Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Rare Disease Clinical Trial introduction, etc. Rare Disease Clinical Trial Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Rare Disease Clinical Trial
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Disease Clinical Trial Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Stage I
1.2.3 Phase II
1.3 Market by Application
1.3.1 Global Rare Disease Clinical Trial Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Autoimmunity and Inflammation
1.3.3 Blood System Disease
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rare Disease Clinical Trial Market Perspective (2018-2033)
2.2 Global Rare Disease Clinical Trial Growth Trends by Region
2.2.1 Rare Disease Clinical Trial Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Rare Disease Clinical Trial Historic Market Size by Region (2018-2023)
2.2.3 Rare Disease Clinical Trial Forecasted Market Size by Region (2024-2033)
2.3 Rare Disease Clinical Trial Market Dynamics
2.3.1 Rare Disease Clinical Trial Industry Trends
2.3.2 Rare Disease Clinical Trial Market Drivers
2.3.3 Rare Disease Clinical Trial Market Challenges
2.3.4 Rare Disease Clinical Trial Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Rare Disease Clinical Trial by Players
3.1.1 Global Rare Disease Clinical Trial Revenue by Players (2018-2023)
3.1.2 Global Rare Disease Clinical Trial Revenue Market Share by Players (2018-2023)
3.2 Global Rare Disease Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Rare Disease Clinical Trial, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Rare Disease Clinical Trial Market Concentration Ratio
3.4.1 Global Rare Disease Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Disease Clinical Trial Revenue in 2022
3.5 Global Key Players of Rare Disease Clinical Trial Head office and Area Served
3.6 Global Key Players of Rare Disease Clinical Trial, Product and Application
3.7 Global Key Players of Rare Disease Clinical Trial, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Disease Clinical Trial Breakdown Data by Type
4.1 Global Rare Disease Clinical Trial Historic Market Size by Type (2018-2023)
4.2 Global Rare Disease Clinical Trial Forecasted Market Size by Type (2024-2033)
5 Rare Disease Clinical Trial Breakdown Data by Application
5.1 Global Rare Disease Clinical Trial Historic Market Size by Application (2018-2023)
5.2 Global Rare Disease Clinical Trial Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Rare Disease Clinical Trial Market Size (2018-2033)
6.2 North America Rare Disease Clinical Trial Market Size by Type
6.2.1 North America Rare Disease Clinical Trial Market Size by Type (2018-2023)
6.2.2 North America Rare Disease Clinical Trial Market Size by Type (2024-2033)
6.2.3 North America Rare Disease Clinical Trial Market Share by Type (2018-2033)
6.3 North America Rare Disease Clinical Trial Market Size by Application
6.3.1 North America Rare Disease Clinical Trial Market Size by Application (2018-2023)
6.3.2 North America Rare Disease Clinical Trial Market Size by Application (2024-2033)
6.3.3 North America Rare Disease Clinical Trial Market Share by Application (2018-2033)
6.4 North America Rare Disease Clinical Trial Market Size by Country
6.4.1 North America Rare Disease Clinical Trial Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Rare Disease Clinical Trial Market Size by Country (2018-2023)
6.4.3 North America Rare Disease Clinical Trial Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Rare Disease Clinical Trial Market Size (2018-2033)
7.2 Europe Rare Disease Clinical Trial Market Size by Type
7.2.1 Europe Rare Disease Clinical Trial Market Size by Type (2018-2023)
7.2.2 Europe Rare Disease Clinical Trial Market Size by Type (2024-2033)
7.2.3 Europe Rare Disease Clinical Trial Market Share by Type (2018-2033)
7.3 Europe Rare Disease Clinical Trial Market Size by Application
7.3.1 Europe Rare Disease Clinical Trial Market Size by Application (2018-2023)
7.3.2 Europe Rare Disease Clinical Trial Market Size by Application (2024-2033)
7.3.3 Europe Rare Disease Clinical Trial Market Share by Application (2018-2033)
7.4 Europe Rare Disease Clinical Trial Market Size by Country
7.4.1 Europe Rare Disease Clinical Trial Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Rare Disease Clinical Trial Market Size by Country (2018-2023)
7.4.3 Europe Rare Disease Clinical Trial Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Rare Disease Clinical Trial Market Size (2018-2033)
8.2 China Rare Disease Clinical Trial Market Size by Type
8.2.1 China Rare Disease Clinical Trial Market Size by Type (2018-2023)
8.2.2 China Rare Disease Clinical Trial Market Size by Type (2024-2033)
8.2.3 China Rare Disease Clinical Trial Market Share by Type (2018-2033)
8.3 China Rare Disease Clinical Trial Market Size by Application
8.3.1 China Rare Disease Clinical Trial Market Size by Application (2018-2023)
8.3.2 China Rare Disease Clinical Trial Market Size by Application (2024-2033)
8.3.3 China Rare Disease Clinical Trial Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Rare Disease Clinical Trial Market Size (2018-2033)
9.2 Asia Rare Disease Clinical Trial Market Size by Type
9.2.1 Asia Rare Disease Clinical Trial Market Size by Type (2018-2023)
9.2.2 Asia Rare Disease Clinical Trial Market Size by Type (2024-2033)
9.2.3 Asia Rare Disease Clinical Trial Market Share by Type (2018-2033)
9.3 Asia Rare Disease Clinical Trial Market Size by Application
9.3.1 Asia Rare Disease Clinical Trial Market Size by Application (2018-2023)
9.3.2 Asia Rare Disease Clinical Trial Market Size by Application (2024-2033)
9.3.3 Asia Rare Disease Clinical Trial Market Share by Application (2018-2033)
9.4 Asia Rare Disease Clinical Trial Market Size by Region
9.4.1 Asia Rare Disease Clinical Trial Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Rare Disease Clinical Trial Market Size by Region (2018-2023)
9.4.3 Asia Rare Disease Clinical Trial Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Type
10.2.1 Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Application
10.3.1 Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Country
10.4.1 Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Takeda Pharmaceutical Company
11.1.1 Takeda Pharmaceutical Company Company Details
11.1.2 Takeda Pharmaceutical Company Business Overview
11.1.3 Takeda Pharmaceutical Company Rare Disease Clinical Trial Introduction
11.1.4 Takeda Pharmaceutical Company Revenue in Rare Disease Clinical Trial Business (2018-2023)
11.1.5 Takeda Pharmaceutical Company Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Rare Disease Clinical Trial Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Rare Disease Clinical Trial Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Rare Disease Clinical Trial Introduction
11.3.4 Pfizer Revenue in Rare Disease Clinical Trial Business (2018-2023)
11.3.5 Pfizer Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Rare Disease Clinical Trial Introduction
11.4.4 AstraZeneca Revenue in Rare Disease Clinical Trial Business (2018-2023)
11.4.5 AstraZeneca Recent Developments
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Rare Disease Clinical Trial Introduction
11.5.4 Novartis AG Revenue in Rare Disease Clinical Trial Business (2018-2023)
11.5.5 Novartis AG Recent Developments
11.6 LabCorp
11.6.1 LabCorp Company Details
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Rare Disease Clinical Trial Introduction
11.6.4 LabCorp Revenue in Rare Disease Clinical Trial Business (2018-2023)
11.6.5 LabCorp Recent Developments
11.7 IQVIA
11.7.1 IQVIA Company Details
11.7.2 IQVIA Business Overview
11.7.3 IQVIA Rare Disease Clinical Trial Introduction
11.7.4 IQVIA Revenue in Rare Disease Clinical Trial Business (2018-2023)
11.7.5 IQVIA Recent Developments
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Details
11.8.2 Charles River Laboratories Business Overview
11.8.3 Charles River Laboratories Rare Disease Clinical Trial Introduction
11.8.4 Charles River Laboratories Revenue in Rare Disease Clinical Trial Business (2018-2023)
11.8.5 Charles River Laboratories Recent Developments
11.9 Icon PLC
11.9.1 Icon PLC Company Details
11.9.2 Icon PLC Business Overview
11.9.3 Icon PLC Rare Disease Clinical Trial Introduction
11.9.4 Icon PLC Revenue in Rare Disease Clinical Trial Business (2018-2023)
11.9.5 Icon PLC Recent Developments
11.10 Parexel International Corporation
11.10.1 Parexel International Corporation Company Details
11.10.2 Parexel International Corporation Business Overview
11.10.3 Parexel International Corporation Rare Disease Clinical Trial Introduction
11.10.4 Parexel International Corporation Revenue in Rare Disease Clinical Trial Business (2018-2023)
11.10.5 Parexel International Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Rare Disease Clinical Trial Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Stage I
Table 3. Key Players of Phase II
Table 4. Global Rare Disease Clinical Trial Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Rare Disease Clinical Trial Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Rare Disease Clinical Trial Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Rare Disease Clinical Trial Market Share by Region (2018-2023)
Table 8. Global Rare Disease Clinical Trial Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Rare Disease Clinical Trial Market Share by Region (2024-2033)
Table 10. Rare Disease Clinical Trial Market Trends
Table 11. Rare Disease Clinical Trial Market Drivers
Table 12. Rare Disease Clinical Trial Market Challenges
Table 13. Rare Disease Clinical Trial Market Restraints
Table 14. Global Rare Disease Clinical Trial Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Rare Disease Clinical Trial Revenue Share by Players (2018-2023)
Table 16. Global Top Rare Disease Clinical Trial by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Clinical Trial as of 2022)
Table 17. Global Rare Disease Clinical Trial Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Rare Disease Clinical Trial Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Rare Disease Clinical Trial, Headquarters and Area Served
Table 20. Global Key Players of Rare Disease Clinical Trial, Product and Application
Table 21. Global Key Players of Rare Disease Clinical Trial, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rare Disease Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Rare Disease Clinical Trial Revenue Market Share by Type (2018-2023)
Table 25. Global Rare Disease Clinical Trial Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Rare Disease Clinical Trial Revenue Market Share by Type (2024-2033)
Table 27. Global Rare Disease Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Rare Disease Clinical Trial Revenue Share by Application (2018-2023)
Table 29. Global Rare Disease Clinical Trial Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Rare Disease Clinical Trial Revenue Share by Application (2024-2033)
Table 31. North America Rare Disease Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Rare Disease Clinical Trial Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Rare Disease Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Rare Disease Clinical Trial Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Rare Disease Clinical Trial Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Rare Disease Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Rare Disease Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Rare Disease Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Rare Disease Clinical Trial Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Rare Disease Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Rare Disease Clinical Trial Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Rare Disease Clinical Trial Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Rare Disease Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Rare Disease Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Rare Disease Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Rare Disease Clinical Trial Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Rare Disease Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Rare Disease Clinical Trial Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Rare Disease Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Rare Disease Clinical Trial Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Rare Disease Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Rare Disease Clinical Trial Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Rare Disease Clinical Trial Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Rare Disease Clinical Trial Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Rare Disease Clinical Trial Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Rare Disease Clinical Trial Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 63. Takeda Pharmaceutical Company Company Details
Table 64. Takeda Pharmaceutical Company Business Overview
Table 65. Takeda Pharmaceutical Company Rare Disease Clinical Trial Product
Table 66. Takeda Pharmaceutical Company Revenue in Rare Disease Clinical Trial Business (2018-2023) & (US$ Million)
Table 67. Takeda Pharmaceutical Company Recent Developments
Table 68. F. Hoffmann-La Roche Company Details
Table 69. F. Hoffmann-La Roche Business Overview
Table 70. F. Hoffmann-La Roche Rare Disease Clinical Trial Product
Table 71. F. Hoffmann-La Roche Revenue in Rare Disease Clinical Trial Business (2018-2023) & (US$ Million)
Table 72. F. Hoffmann-La Roche Recent Developments
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Rare Disease Clinical Trial Product
Table 76. Pfizer Revenue in Rare Disease Clinical Trial Business (2018-2023) & (US$ Million)
Table 77. Pfizer Recent Developments
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Rare Disease Clinical Trial Product
Table 81. AstraZeneca Revenue in Rare Disease Clinical Trial Business (2018-2023) & (US$ Million)
Table 82. AstraZeneca Recent Developments
Table 83. Novartis AG Company Details
Table 84. Novartis AG Business Overview
Table 85. Novartis AG Rare Disease Clinical Trial Product
Table 86. Novartis AG Revenue in Rare Disease Clinical Trial Business (2018-2023) & (US$ Million)
Table 87. Novartis AG Recent Developments
Table 88. LabCorp Company Details
Table 89. LabCorp Business Overview
Table 90. LabCorp Rare Disease Clinical Trial Product
Table 91. LabCorp Revenue in Rare Disease Clinical Trial Business (2018-2023) & (US$ Million)
Table 92. LabCorp Recent Developments
Table 93. IQVIA Company Details
Table 94. IQVIA Business Overview
Table 95. IQVIA Rare Disease Clinical Trial Product
Table 96. IQVIA Revenue in Rare Disease Clinical Trial Business (2018-2023) & (US$ Million)
Table 97. IQVIA Recent Developments
Table 98. Charles River Laboratories Company Details
Table 99. Charles River Laboratories Business Overview
Table 100. Charles River Laboratories Rare Disease Clinical Trial Product
Table 101. Charles River Laboratories Revenue in Rare Disease Clinical Trial Business (2018-2023) & (US$ Million)
Table 102. Charles River Laboratories Recent Developments
Table 103. Icon PLC Company Details
Table 104. Icon PLC Business Overview
Table 105. Icon PLC Rare Disease Clinical Trial Product
Table 106. Icon PLC Revenue in Rare Disease Clinical Trial Business (2018-2023) & (US$ Million)
Table 107. Icon PLC Recent Developments
Table 108. Parexel International Corporation Company Details
Table 109. Parexel International Corporation Business Overview
Table 110. Parexel International Corporation Rare Disease Clinical Trial Product
Table 111. Parexel International Corporation Revenue in Rare Disease Clinical Trial Business (2018-2023) & (US$ Million)
Table 112. Parexel International Corporation Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Disease Clinical Trial Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Rare Disease Clinical Trial Market Share by Type: 2022 VS 2033
Figure 3. Stage I Features
Figure 4. Phase II Features
Figure 5. Global Rare Disease Clinical Trial Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Rare Disease Clinical Trial Market Share by Application: 2022 VS 2033
Figure 7. Autoimmunity and Inflammation Case Studies
Figure 8. Blood System Disease Case Studies
Figure 9. Other Case Studies
Figure 10. Rare Disease Clinical Trial Report Years Considered
Figure 11. Global Rare Disease Clinical Trial Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Rare Disease Clinical Trial Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Rare Disease Clinical Trial Market Share by Region: 2022 VS 2033
Figure 14. Global Rare Disease Clinical Trial Market Share by Players in 2022
Figure 15. Global Top Rare Disease Clinical Trial Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Clinical Trial as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Rare Disease Clinical Trial Revenue in 2022
Figure 17. North America Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Rare Disease Clinical Trial Market Share by Type (2018-2033)
Figure 19. North America Rare Disease Clinical Trial Market Share by Application (2018-2033)
Figure 20. North America Rare Disease Clinical Trial Market Share by Country (2018-2033)
Figure 21. United States Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Rare Disease Clinical Trial Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Rare Disease Clinical Trial Market Share by Type (2018-2033)
Figure 25. Europe Rare Disease Clinical Trial Market Share by Application (2018-2033)
Figure 26. Europe Rare Disease Clinical Trial Market Share by Country (2018-2033)
Figure 27. Germany Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Rare Disease Clinical Trial Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Rare Disease Clinical Trial Market Share by Type (2018-2033)
Figure 35. China Rare Disease Clinical Trial Market Share by Application (2018-2033)
Figure 36. Asia Rare Disease Clinical Trial Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Rare Disease Clinical Trial Market Share by Type (2018-2033)
Figure 38. Asia Rare Disease Clinical Trial Market Share by Application (2018-2033)
Figure 39. Asia Rare Disease Clinical Trial Market Share by Region (2018-2033)
Figure 40. Japan Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Rare Disease Clinical Trial Market Share by Country (2018-2033)
Figure 50. Brazil Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Rare Disease Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Takeda Pharmaceutical Company Revenue Growth Rate in Rare Disease Clinical Trial Business (2018-2023)
Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Rare Disease Clinical Trial Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Rare Disease Clinical Trial Business (2018-2023)
Figure 59. AstraZeneca Revenue Growth Rate in Rare Disease Clinical Trial Business (2018-2023)
Figure 60. Novartis AG Revenue Growth Rate in Rare Disease Clinical Trial Business (2018-2023)
Figure 61. LabCorp Revenue Growth Rate in Rare Disease Clinical Trial Business (2018-2023)
Figure 62. IQVIA Revenue Growth Rate in Rare Disease Clinical Trial Business (2018-2023)
Figure 63. Charles River Laboratories Revenue Growth Rate in Rare Disease Clinical Trial Business (2018-2023)
Figure 64. Icon PLC Revenue Growth Rate in Rare Disease Clinical Trial Business (2018-2023)
Figure 65. Parexel International Corporation Revenue Growth Rate in Rare Disease Clinical Trial Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries